Urinary gonadotropin peptide in patients with cancers of digestive organs

Anticancer Research

Volumn 16, Issue 4 A, 1996, Pages 2041-2048

  Motoo, Yoshiharu ^a   Watanabe, Hiroyuki ^a   Yamaguchi, Yasushi ^a   Mouri, Ikurou ^a   Fujii, Tomoharu ^a   Yamakawa, Osamu ^a   Satomura, Yoshitake ^a   Okai, Takashi ^a   Sawabu, Norio ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Cancers of digestive organs; Tumor marker; Urinary gonadotropin peptide

Indexed keywords

GONADOTROPIN; TUMOR MARKER;

ARTICLE; BILIARY TRACT CANCER; CANCER SURGERY; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; ENZYME IMMUNOASSAY; ESOPHAGUS CANCER; FEMALE; HORMONE URINE LEVEL; HUMAN; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; POSTMENOPAUSE; PRIORITY JOURNAL; STOMACH CANCER;

AGED; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; CREATININE; DIGESTIVE SYSTEM NEOPLASMS; FEMALE; GALLBLADDER NEOPLASMS; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PEPTIDE FRAGMENTS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SEX CHARACTERISTICS; TUMOR MARKERS, BIOLOGICAL;

EID: 0029740471     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Cole LA, Wang Y, Elliott M, et al: Urinary human chorionic gonadotropin free ß-subunit and ß-core fragment: A new marker of gynecological cancers. Cancer Res 48: 1356-1360, 1988.
2. Birken S, Armstrong EG, Kolks MAG, et al: Structure of the human chorionic gonadotropin ß-subunit fragment from pregnancy urine. Endocrinology 123: 572-583, 1988.
3. Cole LA, Schwartz PE, and Wang Y: Urinary gonadotropin fragments (UGF) in cancers of the female reproductive system. Gynecol Oncol 31: 82-90, 1988.
4. Inaba N, Okajima Y, Fukasawa I, et al: Clinical significance of urinary gonadotropin peptide (UGP) as tumor marker for gynecologic malignancies: A comparative study with urinary human chorionic gonadotropin-ß core fragment (BCF), carbohydrate antigen 125 (CA125) and squamous cell carcinoma-associated antigen (SCC). Chiha Med J 69. 327-335, 1993.
5. Tanaka J, Takashi M, Okamura K, et al: Urinary hCGß-core fragment as a tumor marker for urological malignancies. Proc 12th Annu Meet Tumor Marker 8: 254-266, 1992 (in Japanese).
6. Yamanaka N, Kawabata G, Morisue K, et al: Urinary hCG ß-core fragment as a tumor marker for bladder cancer. Jpn J Urol 84: 700-706, 1993 (in Japanese with English abstract).
7. Mckechnie JC and Fechner RE: Choriocarcinoma and adenocarcinoma of the esophagus with gonadotropin secretion. Cancer 27: 694-702, 1971.
8. Braunstein GD, Vaitukaitis JL, Carbone PP et al: Ectopic production of human chorionic gonadotrophin by neoplasms. Ann Intern Med 78: 39-45, 1973.
9. Mori H, Soeda O, Kamano T et al: Choriocarcinomatous change with immunocytochemically HCG-posrtive cells in the gastric carcinoma of the males. Virchows Arch [Pathol Anat] 396: 141-153, 1982.
10. Nakanuma Y, Unoura M, Noto Y et al: Human chorionic gonadotropin in primary liver carcinoma in adults: An immunohistochemical study. Virchows Arch [Pathol Anat] 409: 365-373, 1986.
11. O'Connor JF, Schlatterer JP, Birken S et al: Development of highly sensitive immunoassays to measure human chorionic gonadotropin, its ß-subunit, and ß-core fragment in the urine: application to malignancies. Cancer Res 48: 1361-1366, 1988.
12. Krichevsky A, Birken S, O'Connor J, et al: Development and characterization of a new, highly specific antibody to the human chorionic gonadotropin-ß fragment. Endocrinology 128: 1255-1264, 1991.
13. Japanese Research Society for Gastric Cancer: The general rules for the gastric cancer study in surgery and pathology. Jpn J Surg 11: 127-139, 1981.
14. Japanese Research Society for Cancer of the Colon and Rectum: General rules for clinical and pathological studies on cancer of the colon, rectum and anus. Jpn J Surg 13: 574-598, 1983.
15. Bonsnes RW and Taussky HH: On the colorimetric determination of creatinine by the Jaffe reaction. J Biol Chem 158: 581-591, 1945.
16. Wehmann RE, Blithe DL, Flack MR et al: Metabolic clearance rate and urinary clearance of purified ß-core. J Clin Endocrinol Metab 69: 510-517, 1989.
17. Kardana A and Cole LA: Serum hCG ß-core fragment is masked by associated macromolecules. J Clin Endocrinol Metab 71: 1393-1395, 1990.
18. Cole LA and Nam LH: Urinary gonadotropin fragment (UGF) measurements in diagnosis and management of ovarian cancer. Yale J Biol Med 62: 367-378, 1989.
19. Papapetrou PD, Sakarelou NP, Braouzi H et al: Ectopic production of human chorionic gonadotropin (hCG) by neoplasms:the value of measurements of immunoreactive hCG in the urine as a screening procedure. Cancer 45: 2583-2592, 1980.
20. Izumi R, Hirosawa H, Yabushita K et al: Human chorionic gonadotropin as a tumor marker for intrahepatic cholangiocarcinoma. J Clin Exp Med (IGAKU NO AYUMI) 135: 1009-1010, 1985 (in Japanese).
21. Motoo Y, Satomura Y, Kawakami H et al: Serum levels of tumorassociated glycoprotein (TAG-72) in digestive cancers. Oncology 47: 456-462, 1990.
22. Fukuda T and Ohnishi Y: Gallbladder carcinoma producing human chorionic gonadotropin. Am J Gastroenterol 85: 1403-1406, 1990.
23. Pierce GB: Neoplasms, differentiations and mutations. Am J Pathol 77: 103-118, 1974.
24. Chen H-C, Hodgen GD, Matsuura S et al: Evidence for a gonadotropin from nonpregnant subjects that has physical, immunological, and biological similarities to human chorionic gonadotropin. Proc Natl Acad Sci USA 73: 2885-2889, 1976.
25. Motoo Y, Sawabu N, Yamaguchi Y et al: Serum levels of c-erbB-2 protein in digestive diseases. J Gastroenterol 29: 616-620, 1994.